Genscript Biotech Corporation (1548.HK)
HKD 9.95
(0.2%)
HKD 9.95
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -286.91 Million | -120.29 Million | -136.79 Million | -151.09 Million | -29.95 Million | 307.65 Million |
| Net Income | -350.97 Million | -226.85 Million | -358.71 Million | -204.94 Million | -96.91 Million | 21.21 Million |
| Depreciation & Amortization | 74.04 Million | 61.18 Million | 45.86 Million | 32.33 Million | 20.36 Million | 12.33 Million |
| Deferred income taxes | - | -88.98 Million | -26.12 Million | 67.23 Million | 11.67 Million | -215.25 Million |
| Stock-based compensation | 60.59 Million | 65.15 Million | 39.69 Million | 17.63 Million | 10.78 Million | 8.85 Million |
| Change in working capital | -86.9 Million | 23.82 Million | -13.56 Million | -84.87 Million | -22.45 Million | 206.4 Million |
| Other non-cash items | -47.56 Million | 45.37 Million | 176.05 Million | 21.52 Million | 46.59 Million | 274.1 Million |
| Investing Cash Flow | -357.72 Million | -443.29 Million | -212.54 Million | -100.16 Million | -208.63 Million | -193.96 Million |
| Investments in PPE | -157.71 Million | -216.11 Million | -133.04 Million | -121.87 Million | -110.37 Million | -70.83 Million |
| Acquisitions | -12.65 Million | -914 Thousand | 78.58 Million | -2.06 Million | 100.17 Million | -29.48 Million |
| Investment purchases | -5.74 Billion | -409.62 Million | -322.56 Million | -430.72 Million | -1.33 Billion | -74.99 Million |
| Sales/Maturities of investments | 5.66 Billion | 187.69 Million | 243.98 Million | 462.98 Million | 1.23 Billion | 830 Thousand |
| Other Investing Activities | -103.84 Million | -4.34 Million | -79.5 Million | -8.48 Million | -98.26 Million | -19.47 Million |
| Financing Cash Flow | 1.06 Billion | 419.31 Million | 902.14 Million | 624.2 Million | -2.77 Million | 257.32 Million |
| Debt repayment | -49.78 Million | -7.38 Million | -74.93 Million | -30.59 Million | -20.4 Million | -10.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -9.46 Million | -7.77 Million | -11.47 Million |
| Common Stock Issuance | 1.03 Billion | 423.3 Million | 951.22 Million | 459.56 Million | 3.73 Million | 253.97 Million |
| Other Financing Activities | -2.23 Million | 3.39 Million | 25.84 Million | 624.2 Million | 46.11 Million | 14.82 Million |
| Accounts receivables | -116.98 Million | 38.06 Million | 1.56 Million | -69.9 Million | -14.04 Million | 211.8 Million |
| Accounts payables | - | -106.77 Million | -144.6 Million | -31.48 Million | -74.75 Million | - |
| Inventory | -3.92 Million | -14.23 Million | -15.13 Million | -14.96 Million | -8.41 Million | -5.4 Million |
| Other working capital | -29.73 Million | 106.77 Million | 144.6 Million | 31.48 Million | 74.75 Million | -3.27 Million |
| Cash at beginning of period | 1.02 Billion | 1.18 Billion | 629.05 Million | 252.39 Million | 494.55 Million | 123.85 Million |
| Cash at end of period | 1.44 Billion | 1.02 Billion | 1.18 Billion | 629.05 Million | 252.39 Million | 494.55 Million |
| Capital Expenditure | -157.71 Million | -216.11 Million | -133.04 Million | -121.87 Million | -110.37 Million | -70.83 Million |
| Effect of forex changes on cash | -1.21 Million | -12.7 Million | -890 Thousand | 3.71 Million | -795 Thousand | -318 Thousand |
| Net cash flow / Change in cash | 422.4 Million | -156.97 Million | 551.91 Million | 376.66 Million | -242.16 Million | 370.7 Million |
| Free Cash Flow | -444.62 Million | -336.4 Million | -269.83 Million | -272.97 Million | -140.32 Million | 236.82 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -175.11 Million | -1.89 Million | -350.97 Million | -93.58 Million | -91.34 Million | -226.85 Million |
| Depreciation & Amortization | 40.29 Million | 38.52 Million | 74.04 Million | 35.52 Million | 31.16 Million | 61.18 Million |
| Deferred income taxes | - | - | - | -8.99 Million | -17.58 Million | -88.98 Million |
| Stock-based compensation | 53.34 Million | 21.73 Million | 60.59 Million | 38.85 Million | 28.7 Million | 65.15 Million |
| Change in working capital | 93.17 Million | -94.5 Million | -86.9 Million | -56.15 Million | 96.39 Million | 23.82 Million |
| Other non-cash items | 68.14 Million | -63.6 Million | -47.56 Million | -111.81 Million | -123.2 Million | 45.37 Million |
| Investing Cash Flow | -1.13 Billion | 96.81 Million | -357.72 Million | -454.54 Million | -106.42 Million | -443.29 Million |
| Investments in PPE | -134.02 Million | -172.24 Million | -157.71 Million | -80.19 Million | -142.18 Million | -216.11 Million |
| Acquisitions | - | - | -12.65 Million | - | - | -914 Thousand |
| Investment purchases | - | - | -5.74 Billion | - | - | -409.62 Million |
| Sales/Maturities of investments | - | - | 5.66 Billion | - | - | 187.69 Million |
| Other Investing Activities | -999.02 Million | 269.06 Million | -103.84 Million | -374.34 Million | 35.76 Million | -4.34 Million |
| Financing Cash Flow | 5.56 Million | 48.24 Million | 1.06 Billion | 1.02 Billion | 411.08 Million | 419.31 Million |
| Debt repayment | -22.26 Million | - | -49.78 Million | -2.4 Million | - | -7.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.03 Billion | - | - | 423.3 Million |
| Other Financing Activities | 27.83 Million | 48.24 Million | -2.23 Million | 1.02 Billion | 411.08 Million | 3.39 Million |
| Accounts receivables | 83.28 Million | -86.37 Million | -116.98 Million | -30.61 Million | -405 Thousand | 38.06 Million |
| Accounts payables | - | - | - | - | - | -106.77 Million |
| Inventory | -4.91 Million | -4.67 Million | -3.92 Million | 748 Thousand | -5.33 Million | -14.23 Million |
| Other working capital | 14.8 Million | -3.44 Million | -29.73 Million | -26.28 Million | 102.12 Million | 106.77 Million |
| Cash at beginning of period | 1.44 Billion | 1.39 Billion | 1.02 Billion | 1.02 Billion | 782.24 Million | 1.18 Billion |
| Cash at end of period | 399.29 Million | 1.44 Billion | 1.44 Billion | 1.39 Billion | 1.02 Billion | 1.02 Billion |
| Capital Expenditure | -134.02 Million | -172.24 Million | -157.71 Million | -80.19 Million | -142.18 Million | -216.11 Million |
| Effect of forex changes on cash | 528 Thousand | 3.75 Million | -1.21 Million | -4.97 Million | -4.61 Million | -12.7 Million |
| Net cash flow / Change in cash | -1.04 Billion | 49.06 Million | 422.4 Million | 373.33 Million | 241.75 Million | -156.97 Million |
| Free Cash Flow | -54.17 Million | -271.99 Million | -444.62 Million | -267.36 Million | -200.48 Million | -336.4 Million |
007340
0P2J
GLWLF
NAU
ALI
MODIS